clinical practice
Trials and tribulations
Can a reliable COVID-19
vaccine be developed
as soon as we’d like?
David Paterson interviewed by Conor Burke
A
lot
has been said about how we
might get out of this pandemic
and back to some semblance of
normality. Many people, including some of
our experts and top politicians, have said
that a full return to our old way of life will
only happen when a vaccine is discovered.
Some experts initially said a year to 18
months was achievable, but is that really
likely? It took 28 years to find vaccines for
the flu and chicken pox and researchers
don’t expect to see an HIV vaccine readily
available until 2030, that’s 50 years after
the initial outbreak.
Add to that the fact that we also
haven’t found vaccines for other forms
of coronavirus, and our odds seem
somewhat bleak.
But there are experts around the world
working on solutions, including the use of
existing drugs for treatment of COVID-19.
Professor David Paterson, the director
of the University of Queensland Centre
for Clinical Research, is one of those
researchers and he is involved in clinical
trials of existing drugs on patients in
Queensland hospitals.
22 | nursingreview.com.au
Patterson spoke with Nursing review
in May about the trials and the race for a
coronavirus cure.
NR: What is the state of play in regards to
a cure or treatment for this coronavirus
as you see it?
DP: While we’re all on the edge of our
seats wondering when we are going
to get back to normal, the bad news
is that it’s certainly not going to be in
2020, I think, in terms of finding a very
effective treatment or a vaccine. I think
we’re going to be waiting until 2021 or
even beyond.
It’s important to differentiate treatments
and vaccines. I guess it’s probably better to
get rid of the terminology ‘cure’, because
that’s something we don’t really use
much in medicine and I think it clouds the
issue really.
Typically we’ve said for viral infections
that we don’t have many effective
treatments, unlike bacterial infections
for which we have antibiotics. There’s
no doubt that there are many infections
that are due to bacteria, and if we give an
antibiotic, we can get rid of those bacteria
and a person’s symptoms completely
resolve and they get on with their life.
But there’s not really many antivirals that
truly do completely eradicate an infection,
and without a risk of the infection
reoccurring or, in the situation with HIV,
for example, where we can truly say that
we’ve got rid of the virus because we
know, of course, if a person who is on an
anti-HIV drug stopped their medications it
would come back.
With coronavirus we’ve got two things
happening. One is the virus itself, and
the other is the body’s immune response
to that viral infection. You might say,
“Well, the body’s immune response
is surely only going to be a positive
thing. It’s going to help get rid of the
viral infection.” But we find in many
viruses, including this novel coronavirus,
that the immune response sometimes
goes overboard and that is certainly a
contributor to some of the problems that
people develop.
First of all, we would evaluate whether
there are drugs that we can use to kill the
virus. What we’ve heard a lot about in the
news recently is remdesivir, which is a drug
that was developed to treat Ebola, and
which has some activity against the novel
coronavirus. We’ve heard leaked reports,
we’ve heard little snippets from the results
of trials, but we don’t really know how well
this drug works.
It certainly doesn’t appear to be
something that it works universally, and